When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price […]
Author Archives: april@madhedgefundtrader.com
Mad Hedge Technology Letter February 18, 2026 Fiat Lux Featured Trade: (EXPENSIVE ENERGY A BIG WORRY) (AI)
One of the forgotten risks to AI is the energy capacity situation in the United States. Many people forget that AI will require immense energy with a horde of energy-guzzling data centers to facilitate the next tech revolution. Many consumers have come to realize how the cost of energy has skyrocketed lately, and no doubt […]
“Love your Enemies, for they tell you your faults.” – Said Benjamin Franklin
Strategy’s (MSTR) carrying $8.2 billion in debt, most of it convertible, with $2.25 billion in cash reserves and over 714,000 Bitcoin (BTC) on the balance sheet. The CEO says Bitcoin would need to drop to $8,000 and sit there for five years before they’d have a real problem. The bears say this is a leveraged […]
(TO UNDERSTAND WHAT THE FUTURE HOLDS, WE NEED TO DELVE INTO HISTORY) February 18, 2026 Hello everyone WEEK AHEAD CALENDAR Monday, Feb. 16 NYSE closed for Presidents Day Tuesday, Feb. 17 8:30 a.m. Empire State Index (February) 10 a.m. NAHB Housing Market Index (February) Earnings: EQT, Devon Energy, Cadence Design […]
Global Market Comments February 18, 2026 Fiat Lux Featured Trade: (THE NEW OFFSHORE CENTER: AMERICA), (SIGN UP NOW FOR TEXT MESSAGING OF TRADE ALERTS)
Yahoo is occasionally down in various parts of the country. AWeber, the service provider we use to send out the Trade Alerts by email, sometimes goes completely down for hours and initially denies that the problem was at their end. They blamed a surge in Internet traffic (probably another battle in the ongoing cyber war […]
Mad Hedge Biotech and Healthcare Letter February 17, 2026 Fiat Lux Featured Trade: (A SURVIVOR OF THE GLP-1 MASSACRE) (VKTX), (NVO), (LLY)
The GLP-1 stock massacre of 2025 was brutal, indiscriminate, and thoroughly predictable. Viking Therapeutics (VKTX) got caught in the crossfire, dropping from its peak alongside every other obesity drug hopeful when the market decided a price war was imminent. I watched the selling cascade through the sector like an avalanche, taking down pre-revenue biotechs and […]
